Healthcare Services Group, Inc.

NASDAQ:HCSG

Medical - Care Facilities

Healthcare
$25.10 +1.74%

+$0.39 today

Market cap
$1.69B
Beta
0.83
P/E (TTM)
23.4
EPS (TTM)
$0.97
52W Low $12.66High $24.39

Volume 0.62M

Average 0.69M

HCSG EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Healthcare Services Group, Inc.NASDAQ: HCSG

EBITDA · Q1 FY2026 · quarter ended Mar 2026

EBITDA growth accelerates

Q1 FY2026 EBITDA of $38.35M rose 36.1% year over year, ahead of the +28.0% change in trailing-twelve-month EBITDA. Sequentially, it rose 16.9% from the prior quarter. Over 3 fiscal years it compounded at +11.1% a year.

Context

  • EBITDA amounted to 4.7% of revenue in FY2025, up 0.4 pp from a year earlier.
  • EBITDA increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 5 analysts of $146.87M (+70.3%) for the fiscal year ending Dec 2026, a step up from the +16.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$38.35M+16.9% QoQ
Last fiscal yearDec 2025
$86.22M+16.6% YoY
LTMMar 2026
$96.4M+28.0% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+36.1%+165.1%+129.0 pp
1 year+16.6%+70.3%+53.8 pp
3-year CAGR+11.1%+21.6%+10.5 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
86.22M USD
Year-over-year change
+16.6%
4-year CAGR
+1.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How HCSG compares with its peers on the latest reported figures

  • HCSG's LTM Mar 2026 EBITDA of $96.4M is the 7th highest of the 11 companies compared; the peer median is $104.34M.
  • Its year-over-year change of +28.0% is the 3rd highest of 11, against a peer median of -12.1%.
  • EBITDA amounts to 5.2% of revenue for HCSG, versus a peer median of 12.4%.
HCSG Competitors Peer median
EBITDA for HCSG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SEMSelect Medical Holdings CorporationLTM Mar 2026$518.25M +57.7%-5.8%9.4%
AHCOAdaptHealth Corp.LTM Apr 2026$462.48M -25.4%-7.2%16.2%
GDRXGoodRx Holdings, Inc.LTM Mar 2026$173.34M +1.2%+41.4%22.0%
CNMDCONMED CorporationLTM Mar 2026$169.63M -31.6%+170.6%12.4%
NEOGNeogen CorporationLTM Aug 2026$105.13M +112.0%+9.9%11.9%
USPHU.S. Physical Therapy, Inc.LTM Mar 2026$103.54M +13.1%+13.0%14.2%
HCSGHealthcare Services Group, Inc.LTM Mar 2026$96.4M +28.0%+11.1%5.2%
PNTGThe Pennant Group, Inc.LTM Mar 2026$60.01M +22.5%+51.2%5.9%
NVAXNovavax, Inc.LTM Mar 2026-$42.13M -107.6%—7.1%
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026-$128M -87.3%—152.9%
ZBIOZenas BioPharma, Inc.LTM Mar 2026-$408.44M -151.5%——
Peer median (excluding HCSG) $104.34M-12.1%+13.0%12.4%

Competitors are the stored peer set for HCSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.64B1.69B1.67B1.72B1.84B
Cost of Revenue1.41B1.5B1.46B1.49B1.6B
Gross Profit230.57M193.31M214.75M228.09M239.41M
Gross Margin14.0%11.4%12.8%13.3%13.0%
Research & Development00000
Selling, General & Admin166.43M149.52M160.09M174.82M190.87M
Operating Expenses166.43M149.52M160.09M174.82M190.87M
Depreciation & Amortization14.67M15.32M14.34M14.59M16.78M
EBITDA81.56M62.86M75.26M73.96M86.22M
EBITDA Margin5.0%3.7%4.5%4.3%4.7%
Operating Income64.13M43.79M54.66M53.27M48.54M
Operating Margin3.9%2.6%3.3%3.1%2.6%
Interest Income00000
Interest Expense1.39M2.99M7.86M6.44M1.58M
Other Income / Expenses1.38M764K(1.6M)(330K)19.33M
Income Before Tax65.51M44.55M53.06M52.94M67.87M
Pre-Tax Margin4.0%2.6%3.2%3.1%3.7%
Income Tax Expense16.97M10.31M14.67M13.47M8.81M
Net Income48.54M34.24M38.39M39.47M59.06M
Net Margin3.0%2.0%2.3%2.3%3.2%
EPS (Basic)0.650.460.520.540.82
EPS (Diluted)0.650.460.520.530.81
Weighted Avg Shares74.82M74.34M74.29M73.75M72.38M
Weighted Avg Shares (Diluted)74.96M74.35M74.34M73.99M73.03M

Healthcare Services Group, Inc.

NASDAQ:HCSG

Intrinsic Alpha fair value

Locked

Current Price

$25.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.